The company will take its new price to the provinces and territories, which will then determine if they can afford to carry Procysbi under their drug plans.A yearly cost of about $100,000 is generally seen as the maximum that the plans will cover."When you're getting into the hundreds of thousands of dollars per year for the drug — however the drug companies justify those — ask them to open up their books and show us the figures that mean they need to charge this much.""We … believe it is best to move forward without additional litigation," said company spokesperson Amanda Phraner.Jeff Wright, a spokesperson for the board, said it always prefers to resolve these matters through voluntary compliance."